Sentiment-Signal
32,0
Bearisch
Composite Score (0–100)
Insider (25%)
70.5
9 Insider, 20,7M $ Volumen
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 18.12.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of C |
| 12.11.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | s a result of, or associated with, these actions. Item 5.02. Departure of Directors or Certain Officers; Election of Dir |
| 08.10.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of C |
| 28.08.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of C |
| 06.11.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | rding the Merger and the information set forth in Item 5.02 of this Current Report on Form 8-K regarding the Board and e |
| 14.07.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | The information set forth in Item 1.01 and in Item 5.02 is incorporated by reference into this Item 5.01. Item 5.02. D |
Stammdaten
Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.
Unternehmen & Branche
| Name | Korro Bio, Inc. |
|---|---|
| Ticker | KRRO |
| CIK | 0001703647 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 121,7 Mio. USD |
| Beta | 2,43 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 6,392,000 | -117,260,000 | -12.48 | 113,506,000 | |
| 2025-09-30 | 10-Q | 1,090,000 | -18,061,000 | -1.92 | 161,550,000 | |
| 2025-06-30 | 10-Q | 1,460,000 | -25,770,000 | -2.74 | 180,425,000 | |
| 2025-03-31 | 10-Q | 2,550,000 | -23,387,000 | -2.49 | 202,207,000 | |
| 2024-12-31 | 10-K | 2,271,000 | -83,581,000 | -9.37 | 226,240,000 | |
| 2024-09-30 | 10-Q | 0 | -20,999,000 | -2.26 | 243,543,000 | |
| 2024-06-30 | 10-Q | 0 | -21,826,000 | -2.43 | 249,588,000 | |
| 2024-03-31 | 10-Q | 0 | -19,557,000 | -2.44 | 197,985,000 | |
| 2023-12-31 | 10-K | 0 | -81,172,000 | -53.08 | 221,663,000 | |
| 2023-09-30 | 10-Q | -18,492,000 | -65.08 | 46,349,000 | ||
| 2023-06-30 | 10-Q | -17,649,000 | -63.83 | 79,383,000 | ||
| 2023-03-31 | 10-Q | -19,605,000 | -72.20 | 101,501,000 | ||
| 2022-12-31 | 10-K | 0 | -58,032,000 | -227.42 | 73,742,000 | |
| 2022-09-30 | 10-Q | 0 | -19,547,000 | -0.55 | 136,013,000 | |
| 2022-06-30 | 10-Q | 0 | -21,285,000 | 149,658,000 | ||
| 2022-03-31 | 10-Q | 0 | -23,386,000 | 164,939,000 | ||
| 2021-12-31 | 10-K | 14,068,000 | -84,686,000 | 185,358,000 | ||
| 2021-09-30 | 10-Q | 0 | -25,155,000 | 202,185,000 | ||
| 2021-06-30 | 10-Q | 9,417,000 | -17,656,000 | 220,213,000 | ||
| 2021-03-31 | 10-Q | 4,651,000 | -20,375,000 | 241,511,000 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | Lynx1 Capital Management LP | 10% Owner | Open Market Purchase | 520 | 10.60 | 5,512.00 | +0,3% | |
| 2026-03-10 | Makhzoumi Mohamad | 10% Owner | Open Market Purchase | 207,100 | 11.11 | 2,300,881.00 | +111,1% | |
| 2026-03-10 | Florence Anthony A. Jr. | 10% Owner | Open Market Purchase | 207,100 | 11.11 | 2,300,881.00 | +111,1% | |
| 2026-03-10 | Chang Carmen | 10% Owner | Open Market Purchase | 207,100 | 11.11 | 2,300,881.00 | +111,1% | |
| 2026-03-10 | BASKETT FOREST | 10% Owner | Open Market Purchase | 207,100 | 11.11 | 2,300,881.00 | +111,1% | |
| 2026-03-10 | SANDELL SCOTT D | 10% Owner | Open Market Purchase | 207,100 | 11.11 | 2,300,881.00 | +111,1% | |
| 2026-03-10 | Mathers Edward T | 10% Owner | Open Market Purchase | 207,100 | 11.11 | 2,300,881.00 | +111,1% | |
| 2026-03-10 | Yang Rick | 10% Owner | Open Market Purchase | 207,100 | 11.11 | 2,300,881.00 | +111,1% | |
| 2026-03-10 | New Enterprise Associates 17, L.P. | 10% Owner | Open Market Purchase | 207,100 | 11.11 | 2,300,881.00 | +111,1% | |
| 2026-03-10 | Walker Paul Edward | 10% Owner | Open Market Purchase | 207,100 | 11.11 | 2,300,881.00 | +111,1% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.